about
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor.New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors.4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX InhibitorsNovel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studiesOptimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African TrypanosomiasisDiscovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal StructureDiscovery of Pyrido[3',2':5,6]thiopyrano[4,3-d]pyrimidine-Based Antiproliferative Multikinase Inhibitors
P50
Q39368534-3042E6AF-3C91-4E0E-9E9C-D29B2607EFEBQ50593408-98F682AD-C361-4289-AD84-30EE3A20B072Q52652067-A755A02C-F164-4305-9320-06C7718FE90EQ58856012-8D2543E8-9141-436C-A5C2-A0623C8F9BCBQ90180795-503BB4FF-CB2B-4C20-A4BC-ED89238E401CQ91244105-1B58ABD9-1C36-4F77-97D8-EC62A2B1F53EQ91499991-B2106A84-B3E9-4625-AFD2-332B51D34F2AQ93166626-B8D79E05-E932-4B0F-ACEC-444DECEC2843
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giorgio Amendola
@ast
Giorgio Amendola
@en
Giorgio Amendola
@es
Giorgio Amendola
@nl
type
label
Giorgio Amendola
@ast
Giorgio Amendola
@en
Giorgio Amendola
@es
Giorgio Amendola
@nl
prefLabel
Giorgio Amendola
@ast
Giorgio Amendola
@en
Giorgio Amendola
@es
Giorgio Amendola
@nl
P106
P31
P496
0000-0003-4271-5031